292 related articles for article (PubMed ID: 36016386)
21. Identification of High-Risk Human Papillomavirus DNA, p16, and E6/E7 Oncoproteins in Laryngeal and Hypopharyngeal Squamous Cell Carcinomas.
Lifsics A; Groma V; Cistjakovs M; Skuja S; Deksnis R; Murovska M
Viruses; 2021 May; 13(6):. PubMed ID: 34072187
[TBL] [Abstract][Full Text] [Related]
22. Transforming Properties of Beta-3 Human Papillomavirus E6 and E7 Proteins.
Minoni L; Romero-Medina MC; Venuti A; Sirand C; Robitaille A; Altamura G; Le Calvez-Kelm F; Viarisio D; Zanier K; Müller M; Accardi R; Tommasino M
mSphere; 2020 Jul; 5(4):. PubMed ID: 32669468
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus type 16 E6 and E7 oncoproteins interact with the nuclear p53-binding protein 1 in an in vitro reconstructed 3D epithelium: new insights for the virus-induced DNA damage response.
Squarzanti DF; Sorrentino R; Landini MM; Chiesa A; Pinato S; Rocchio F; Mattii M; Penengo L; Azzimonti B
Virol J; 2018 Nov; 15(1):176. PubMed ID: 30445982
[TBL] [Abstract][Full Text] [Related]
24. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
[TBL] [Abstract][Full Text] [Related]
25. IFN-β antiproliferative effect and miRNA regulation in Human Papilloma Virus E6- and E7-transformed keratinocytes.
Chiantore MV; Mangino G; Iuliano M; Zangrillo MS; De Lillis I; Vaccari G; Accardi R; Tommasino M; Fiorucci G; Romeo G
Cytokine; 2017 Jan; 89():235-238. PubMed ID: 26748726
[TBL] [Abstract][Full Text] [Related]
26. Comparative analysis of transforming properties of E6 and E7 from different beta human papillomavirus types.
Cornet I; Bouvard V; Campo MS; Thomas M; Banks L; Gissmann L; Lamartine J; Sylla BS; Accardi R; Tommasino M
J Virol; 2012 Feb; 86(4):2366-70. PubMed ID: 22171257
[TBL] [Abstract][Full Text] [Related]
27. Involvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced by HPV E6/E7 oncoproteins.
Buonomo T; Carraresi L; Rossini M; Martinelli R
J Transl Med; 2011 Jan; 9():2. PubMed ID: 21205295
[TBL] [Abstract][Full Text] [Related]
28. Disruption of repressive p130-DREAM complexes by human papillomavirus 16 E6/E7 oncoproteins is required for cell-cycle progression in cervical cancer cells.
Nor Rashid N; Yusof R; Watson RJ
J Gen Virol; 2011 Nov; 92(Pt 11):2620-2627. PubMed ID: 21813705
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Epstein-Barr Virus Replication in Human Papillomavirus-Immortalized Keratinocytes.
Guidry JT; Myers JE; Bienkowska-Haba M; Songock WK; Ma X; Shi M; Nathan CO; Bodily JM; Sapp MJ; Scott RS
J Virol; 2019 Jan; 93(2):. PubMed ID: 30381489
[TBL] [Abstract][Full Text] [Related]
30. Reciprocal transactivation of Merkel cell polyomavirus and high-risk human papillomavirus promoter activities and increased expression of their oncoproteins.
Rasheed K; Sveinbjørnsson B; Moens U
Virol J; 2021 Jul; 18(1):139. PubMed ID: 34217322
[TBL] [Abstract][Full Text] [Related]
31. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
32. Tobacco smoke activates human papillomavirus 16 p97 promoter and cooperates with high-risk E6/E7 for oxidative DNA damage in lung cells.
Peña N; Carrillo D; Muñoz JP; Chnaiderman J; Urzúa U; León O; Tornesello ML; Corvalán AH; Soto-Rifo R; Aguayo F
PLoS One; 2015; 10(4):e0123029. PubMed ID: 25830243
[TBL] [Abstract][Full Text] [Related]
33. HPV-inactive cell populations arise from HPV16-transformed human keratinocytes after p53 knockout.
Abboodi F; Buckhaults P; Altomare D; Liu C; Hosseinipour M; Banister CE; Creek KE; Pirisi L
Virology; 2021 Feb; 554():9-16. PubMed ID: 33321328
[TBL] [Abstract][Full Text] [Related]
34. Evidence for alteration of EZH2, BMI1, and KDM6A and epigenetic reprogramming in human papillomavirus type 16 E6/E7-expressing keratinocytes.
Hyland PL; McDade SS; McCloskey R; Dickson GJ; Arthur K; McCance DJ; Patel D
J Virol; 2011 Nov; 85(21):10999-1006. PubMed ID: 21865393
[TBL] [Abstract][Full Text] [Related]
35. The Mus musculus Papillomavirus Type 1 E7 Protein Binds to the Retinoblastoma Tumor Suppressor: Implications for Viral Pathogenesis.
Wei T; Grace M; Uberoi A; Romero-Masters JC; Lee D; Lambert PF; Munger K
mBio; 2021 Aug; 12(4):e0227721. PubMed ID: 34465025
[TBL] [Abstract][Full Text] [Related]
36. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.
Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M
FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561
[TBL] [Abstract][Full Text] [Related]
37. Identification of host transcriptional networks showing concentration-dependent regulation by HPV16 E6 and E7 proteins in basal cervical squamous epithelial cells.
Smith SP; Scarpini CG; Groves IJ; Odle RI; Coleman N
Sci Rep; 2016 Jul; 6():29832. PubMed ID: 27457222
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus 16 E6 and E7 oncoprotein expression alters microRNA expression in extracellular vesicles.
Harden ME; Munger K
Virology; 2017 Aug; 508():63-69. PubMed ID: 28500882
[TBL] [Abstract][Full Text] [Related]
39. E6/E7 and E6
Artaza-Irigaray C; Molina-Pineda A; Aguilar-Lemarroy A; Ortiz-Lazareno P; Limón-Toledo LP; Pereira-Suárez AL; Rojo-Contreras W; Jave-Suárez LF
Front Immunol; 2019; 10():1676. PubMed ID: 31396215
[TBL] [Abstract][Full Text] [Related]
40. Papillomavirus E7 oncoproteins share functions with polyomavirus small T antigens.
White EA; Kramer RE; Hwang JH; Pores Fernando AT; Naetar N; Hahn WC; Roberts TM; Schaffhausen BS; Livingston DM; Howley PM
J Virol; 2015 Mar; 89(5):2857-65. PubMed ID: 25540383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
